Quality Matters | U.S. Pharmacopeia Blog

// March 08, 2022

mRNA Vaccines: Your Questions Answered

Thanks to the vaccines developed to fight the pandemic, mRNA, specifically mRNA vaccines, has become a topic of public interest. Non-scientists want to understand what mRNA vaccines are, how they work and whether they should trust them.

USP Staff

Supply Chain

// March 14, 2022

The medicines supply chain: Increasing visibility to strengthen preparedness ...

We are doing our part by improving visibility into the upstream medicines supply chain so that vulnerabilities can be predicted and addressed before potential disruptions occur. Our solution to aid early detection of risk factors that can lead to drug shortages is USP’s Medicine Supply Map.

Vimala Raghavendran

Global Health

// March 07, 2022

Bolstering capabilities to support the supply of quality medicines...

Strengthening the medicine supply chain is a global imperative and one to which USP has long been committed. Our efforts to help strengthen the medicine supply chain aligns directly with our mission to advance the supply of quality-assured medicines to improve the health and wellbeing of people around the world.

Emily Kaine, M.D.

Healthcare

// March 08, 2022

mRNA Vaccines: Your Questions Answered

USP Staff

Global Health

// May 19, 2022

Fighting maternal mortality: How standards keep new moms safe...

Millions of mothers and infants continue to die from complications associated with pregnancy and childbirth annually, with sub-Saharan Africa and Southeast Asia accounting for the most (86%) maternal deaths. Several medicines are available to treat life-threatening conditions that can develop during childbirth.

Lawrence Evans III

Supply Chain

// February 24, 2022

Advanced manufacturing technology: Reducing barriers to adoption...

We need to reduce the barriers to adoption of advanced manufacturing technology (AMT) like pharmaceutical continuous manufacturing (PCM).

Joseph Hill

Featured Videos

View All Videos

Quality Medicines for Malaria

Global Health

// May 24, 2018

Quality Medicines for Malaria

Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.

Rob Anderson

Poor quality medicines and drug resistance

Global Health

// May 24, 2018

Poor quality medicines and drug resistance

Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.

Rob Anderson

Quality medicines and sub-Saharan Africa

Global Health

// May 24, 2018

Quality medicines and sub-Saharan Africa

Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.

Rob Anderson

Discover More:

I am interested in:

and:

Supply Chain

// May 18, 2022

Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map an...

Since the start of the pandemic, the U.S. government has allocated over $34 billon to improve U.S. medicines supply chain resilience.

Vimala Raghavendran Matthew Christian

Supply Chain

// May 16, 2022

USP Convention Prioritizes Preparedness for a Resilient Supply Chain...

An all-too-familiar experience in recent years, medicines supply chain disruptions can arise from many factors, including pandemics like COVID-19, natural disasters, and geopolitical events like those taking place right now in Eastern Europe.

Shelley Whiddon, M.A.

Supply Chain

// May 13, 2022

Pharmaceutical continuous manufacturing: How USP standards and related programs suppo...

As pharmaceutical continuous manufacturing (PCM) technology captures increasing stakeholder interest as one way to help achieve this goal, USP public quality standards and related programs will remain an essential part of the solution to support quality and innovation and bolster supply chain resilience.

Atul Dubey

USP Leadership

// April 21, 2022

USP volunteering in the spotlight: Tackling critical public health needs...

USP is proud to celebrate and honor the commitment and achievements of over 1,000 Expert Volunteers and Government Liaisons who make our work possible.

Jaap Venema

Supply Chain

// March 11, 2022

Bringing together experts to advance solutions: USP Convention series on supply chain...

The supply chain for medicines is complex and spans the globe – no government, organization, or company has all the solutions or capacity to strengthen the supply chain alone; perspectives, input, expertise, and resources from many sectors are needed.

Shelley Whiddon, M.A.

getting band aide after COVID-19 vaccine

Healthcare

// January 06, 2022

Protecting patient safety by curbing vaccine mix-up errors...

Although mix-ups appear to be rare, these errors in vaccine administration can have serious consequences to patients, including lack of proper protection from a disease, the need to revaccinate, diminished trust in vaccines, and increased healthcare costs.